Stenman UH - Search Results

1

Rippey JH, Wener MH, Horoszewicz J, Stenman UH, Klee GG, Belanger A, Maxim PE, Graves H, Howanitz J, Nakamura RM. Rippey JH, et al. Among authors: stenman uh. Cancer. 1993 Apr 15;71(8):2678. doi: 10.1002/1097-0142(19930415)71:8<2678::aid-cncr2820710839>3.0.co;2-4. Cancer. 1993. PMID: 7680951 No abstract available.

2

Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.

Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Piironen T, Abrahamsson PA, Stenman UH, Dowell B, Lövgren T, Lilja H. Oesterling JE, et al. Among authors: stenman uh. J Urol. 1995 Sep;154(3):1090-5. doi: 10.1016/s0022-5347(01)66984-2. J Urol. 1995. PMID: 7543605 Clinical Trial.

3

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. Stenman UH, et al. Cancer Res. 1991 Jan 1;51(1):222-6. Cancer Res. 1991. PMID: 1703033

4

Standardization of PSA determinations.

Stenman UH, Leinonen J, Zhang WM. Stenman UH, et al. Scand J Clin Lab Invest Suppl. 1995;221:45-51. doi: 10.3109/00365519509090563. Scand J Clin Lab Invest Suppl. 1995. PMID: 7544484 Review.

5

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.

Auvinen A, Tammela T, Stenman UH, Uusi-Erkkilä I, Leinonen J, Schröder FH, Hakama M. Auvinen A, et al. Among authors: stenman uh. Br J Cancer. 1996 Aug;74(4):568-72. doi: 10.1038/bjc.1996.402. Br J Cancer. 1996. PMID: 8761371 Free PMC article. Clinical Trial.

6

Successful separation between benign prostatic hyperplasia and prostate cancer by measurement of free and complexed PSA.

Lilja H, Stenman UH. Lilja H, et al. Among authors: stenman uh. Cancer Treat Res. 1996;88:93-101. doi: 10.1007/978-1-4615-6343-3_5. Cancer Treat Res. 1996. PMID: 9239474 Review. No abstract available.

7

European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Määttänen L, Auvinen A, Stenman UH, Rannikko S, Tammela T, Aro J, Juusela H, Hakama M. Määttänen L, et al. Among authors: stenman uh. Br J Cancer. 1999 Mar;79(7-8):1210-4. doi: 10.1038/sj.bjc.6690194. Br J Cancer. 1999. PMID: 10098761 Free PMC article. Clinical Trial.

8

Prostate-specific antigen.

Stenman UH, Leinonen J, Zhang WM, Finne P. Stenman UH, et al. Semin Cancer Biol. 1999 Apr;9(2):83-93. doi: 10.1006/scbi.1998.0086. Semin Cancer Biol. 1999. PMID: 10202130 Review.

9

[About Psa-screening].

Hakama M, Auvinen A, Stenman UH, Tammela T. Hakama M, et al. Among authors: stenman uh. Duodecim. 1996;112(14):1314-6. Duodecim. 1996. PMID: 10596108 Finnish. No abstract available.

10

Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening.

Finne P, Finne R, Bangma C, Hugosson J, Hakama M, Auvinen A, Stenman UH. Finne P, et al. Among authors: stenman uh. Int J Cancer. 2004 Aug 20;111(2):310-5. doi: 10.1002/ijc.20250. Int J Cancer. 2004. PMID: 15197788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters